Following comprehensive adjustment for potential clinical confounders including tumor stage, differentiation status, and so on, multivariable Cox proportional hazards regression analysis identified GPD1L transcriptional levels (adjusted HR=0.936, 95% CI: 0.880-0.994; P=0.032) and patient age (adjusted HR=1.047, 95% CI: 1.024-1.070; P<0.001) as statistically independent prognostic determinants of overall survival (OS). This evidence concerns the gene GPD1L and neoplasm.